Point View Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Point View Wealth Management's GILD Position: Q4 2020 in Review
Point View Wealth Management increased its Gilead Sciences (GILD) stake by 11% in Q4 2020, buying an estimated $102K and bringing the position to 17,226 shares worth $1M. The position accounts for 0.41% of the portfolio, ranked #79.
Point View Wealth Management first reported a position in GILD in Q1 2016 and has held it in 20 quarters since. The position peaked at $1.25M in Q1 2020. 1,563 funds tracked by Wall St. Rank hold GILD as of Q4 2020.
- Point View Wealth Management held 17,226 shares of Gilead Sciences worth $1M as of Q4 2020.
- Point View Wealth Management bought 1,694 Gilead Sciences shares in Q4 2020, an estimated $102K.
- Gilead Sciences made up 0.41% of Point View Wealth Management's portfolio in Q4 2020, its #79 holding.
- Point View Wealth Management first reported a position in Gilead Sciences in Q1 2016 and has held it in 20 quarters since.
- Point View Wealth Management's Gilead Sciences position peaked at $1.25M in Q1 2020.
- 1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2020.
Based on Point View Wealth Management's 13F filing for Q4 2020, filed 8 Feb 2021.